Delivery Order SPE2DR25D6028-SPE2DR26FAQVA
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for Levophed 4 mg/4 mL vials with a ceiling value of $1,334.19. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. This delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Levophed (norepinephrine) in 4-milliliter vials, quantity 10, with a ceiling value of $1,026.68. The contract employs firm fixed price pricing and carries an ultimate completion date of August 29, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $1,051.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Levophed (norepinephrine) intravenous solution, 4mL vials in a 10-pack unit. The delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive, non-set-aside award. Levophed is a critical vasopressor medication used in emergency and intensive care settings to treat hypotension and maintain...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,802.12 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Levophed (norepinephrine) in 4ml vials, a critical vasopressor medication used in emergency and intensive care settings. This firm fixed-price delivery order, with a completion date of September 29, 2025, was competitively awarded without set-aside designation and will be performed at the contractor's corporate headquarters in...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22D2206) with a ceiling value of $8,808.54 for the supply of 4 mg/4 ml Levophed vials. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
- The Defense Logistics Agency awarded a $16,438.36 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Norepinephrine 8 mg/250 ml in D5W 250 ml formulation, with an ultimate completion date of September 17, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is serving as the prime contractor through its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Norepinephrine 4 mg/4 ml vials with a ceiling value of $1,107.83. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $2,214.96, is for the delivery of LEVEMIR 100 UNIT/ML VIAL 10ML, a specialty pharmaceutical product, to support military treatment programs and facilities. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor on this award, which does not have a...
- The Defense Logistics Agency awarded a $4,782.46 delivery order to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets (100-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside contract employs firm fixed-price pricing and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location for this pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,854.05 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in quantities of 100 units. This firm fixed-price contract was awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside competitive award, reflecting AmerisourceBergen's capability...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FAQVADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,082.00 to AmerisourceBergen Drug Corp for Levophed SDV 4ML in quantities of 10 units. This non-competed delivery order, issued on October 22, 2025, with completion scheduled for October 23, 2025, represents a firm fixed-price pharmaceutical supply transaction. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a major healthcare solutions provider and pharmaceutical distributor. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. Levophed (norepinephrine) is a critical vasoactive medication used in emergency and acute care settings, making this supply essential to maintaining medical readiness across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/22/25 |